2023 May 18, 2023 Video Global Trends in R&D 2023 Activity, Productivity, and Enablers Institute Report The Global Use of Medicines 2023 Outlook to 2027 Fact Sheet COVID-19 Continues to Impact Global Spending on Medicines Based on research in the Institute report on Global Use of ...
This annual trend report from the IQVIA Institute quantifies the impact of market dynamics and examines the spending and usage of medicines in 2023 and the outlook to 2028, globally and for specific therapy areas and countries. This report is intended to
This does not mean prescribing a rigid one-size-fits-all formula. Indeed, regional authorities will adapt the standard to meet their own needs, but the use of global open web standards and open source HL7 FHIR for medicines information data modelling and interoperability ensures ...
Before the implementation of the reform and opening-up policy in 1978, China was relatively closed under the planned economy. All medical resources and health service facilities were run entirely by the state and there was a serious shortage of medicines and medical technologies, with few imported...
Consider the breakthrough work happening here. We’re especially excited about one of the malaria drug candidates GHDDI is working on, in partnership with two international organizations, the Medicines for Malaria Venture and the Malaria Drug Accelerator. ...
In 2023, the World Health Organization (WHO) Model Lists of Essential Medicines, which regularly selects highly effective bio-products with prohibitively high prices, included two more biological agents targeting cancer and multiple sclerosis, partly due to the presence of their biosimilars that offer...
medical bills was realized, with over 57 million applications for settlement approved. We made bulk government purchases of medicines and medical consumables, thus cutting medical bills by more than 400 billion yuan. Thirteen national medical research centers and 76 regional medical centers were opened...
Chinese patent medicines for COVID-19 According to our findings, the applications of Chinese patent medicines (CPMs) fall into four categories: heat-clearing agents, dampness-removing agents, cough suppressants, and tonics. Lianhua Qingwen, Shuanghuanglian Oral Liquid, and Pudilan Xiaoyan oral liquid...
According to the official website of China’s National Medicines and Pharmaceutical Administration (NMPA), a total of 87 novel drugs were approved in China in 2023, with targeted drugs accounting for 67.8% of the total, amounting to 59 drugs (Fig.1a; Table1) [https://www.nmpa.gov.cn/yao...
2023 May 18, 2023 Institute Report The Global Use of Medicines 2022 Institute Report The Use of Medicines in the U.S. 2022 Institute Report Optimizing Oncology Care Through Biomarker Adoption Institute Report Global Medicine Spending and Usage Trends Institute Report Biosimilars in th...